Encephalitis with antibodies to glutamate NMDA receptors (anti-NMDA receptor encephalitis, ANRE) is a relatively common form of autoimmune encephalitis. Clinical symptoms at onset are similar to the symptoms of exacerbation of schizophrenia, such that these patients are often hospitalized in psychiatric institutions. Considering the high lethality of this condition, and also its potential curability, detection of ANRE is an important clinical task. We present here the first laboratory confirmed case of ANRE in the Russian literature. Difficulties preventing the prompt resolution of the condition are presented, along with criteria for its diagnosis and a treatment algorithm.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
R. Vitaliani, W. Mason, B. Ances, et al., “Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma,” Ann. Neurol., 58, No. 4, 594–604 (2005), doi: https://doi.org/10.1002/ana.20614.
J. Dalmau, E. Tüzün, H. Wu, et al., “Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma,” Ann. Neurol., 61, No. 1, 25–36 (2007), doi: https://doi.org/10.1002/ana.21050.
C. Finke, U. Kopp, H. Pruss, et al., “Cognitive deficits following anti-NMDA receptor encephalitis,” J. Neurol. Neurosurg. Psychiatr., 83, No. 2, 195–198 (2011), doi: https://doi.org/10.1136/jnnp-2011-300411.
F. Graus, “Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients,” Brain, 124, No. 6, 1138–1148 (2001), doi: https://doi.org/10.1093/brain/124.6.1138.
S. Irani, S. Alexander, P. Waters, et al., “Antibodies to Kv1 potassium channel complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia,” Brain, 133, No. 9, 2734–2748 (2010), doi: https://doi.org/10.1093/brain/awq213.
H. Pruss, J. Dalmau, L. Harms, et al., “Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin,” Neurology, 75, No. 19, 1735–1739 (2010), doi: https://doi.org/10.1212/WNL.0b013e3181fc2a06.
J. Granerod, H. Ambrose, R. Cunningham, et al., “Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study,” Lancet Infect. Dis., 10, No. 12, 835–844 (2010), doi: https://doi.org/10.1016/S1473-3099(10)70222-X.
T. Iizuka, F. Sakai, T. Ide, et al., “Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal,” Neurology, 70, No. 7, 504–511, (2007) doi.10.1212/01.wnl.0000278388.90370.c3.
L. Sansing, E. Tüzün, M. Ko, et al., “A patient with encephalitis associated with NMDA receptor antibodies,” Nat. Clin. Pract. Neurol., 3, No. 5, 291–296 (2007), doi: https://doi.org/10.1038/ncpneuro0493.
J. Dalmau, E. Lancaster, E. Martinez-Hernandez, et al., “Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis,” Lancet Neurol., 10, No. 1, 63–74 (2011), doi: https://doi.org/10.1016/S1474-4422(10)70253-2.
J. Dalmau, A. Gleichman, E. Hughes, et al., “Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies,” Lancet Neurol., 7, No. 12, 1091–1098 (2008), doi: https://doi.org/10.1016/S1474-4422(08)70224-2.
C. Gitiaux, H. Simonnet, M. Eisermann, et al., “Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children,” Clin. Neurophysiol., 124, No. 12, 2354–2361 (2013), doi: https://doi.org/10.1016/j.clinph.2013.05.023.
T. Iizuka, F. Sakai, T. Ide, et al., “Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal,” Neurology, 70, No. 7, 504–511 (2007), doi: https://doi.org/10.1212/01.wnl.0000278388.90370.c3.
M. Maeder-Ingvar, J. Prior, S. Irani, et al., “FDGPET hyperactivity in basal ganglia correlating with clinical course in anti-NMDA-R antibodies encephalitis,” J. Neurol. Neurosurg. Psychiatry, 82, No. 2, 235–236 (2010), doi: https://doi.org/10.1136/jnnp.2009.198697.
S. Pillai, D. Gill, R. Webster, et al., “Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis,” Pediatr. Neurol., 43, No. 3, 217–220 (2010), doi: https://doi.org/10.1016/j.pediatrneurol.2010. 04.019.
V. Llorens, I. Gabilondo, J. Gómez-Esteban, et al., “Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA receptor encephalitis,” J. Neurol., 257, No. 9, 1568–1569 (2010), doi: https://doi.org/10.1007/s00415-010-5546-z.
N. Florance, R. Davis, C. Lam, et al., “Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents,” Ann. Neurol., 66, No. 1, 11–18 (2009), doi: https://doi.org/10.1002/ana.21756.
S. Irani, K. Bera, P. Waters, et al., “N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes,” Brain, 133, No. 6, 1655–1667 (2010), doi: https://doi.org/10.1093/brain/awq113.
M. Seki, S. Suzuki, T. Iizuka, et al., “Neurological response to early removal of ovarian teratoma in anti- NMDAR encephalitis,” J. Neurol. Neurosurg. Psychiatry, 79, No. 3, 324–326 (2008), doi: https://doi.org/10.1136/jnnp.2007.136473.
A. Lebas, B. Husson, A. Didelot, et al., “Expanding spectrum of encephalitis with NMDA receptor antibodies in young children,” J. Child Neurol., 25, No. 6, 742–745 (2009), doi: https://doi.org/10.1177/0883073809343319.
M. Zandi, S. Irani, G. Follows, et al., “Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma,” Neurology, 73, No. 23, 2039–2040 (2009), doi: https://doi.org/10.1212/wnl.0b013e3181c55e9b.
A. Poduval, Z. Antal, T. Lee, et al., “Immune-mediated encephalitis and virilization in association with a mature cystic ovarian teratoma in an adolescent girl,” Horm. Res., 72, No. 4, 252–256 (2009), doi: https://doi.org/10.1159/000236087.
M. Gable, S. Gavali, A. Radner, et al., “Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis,” Eur. J. Clin. Microbiol. Infect. Dis., 28, No. 12, 421–1429 (2009), doi: https://doi.org/10.1007/s10096-009-0799-0.
S. Baltagi, M. Shoykhet, K. Felmet, et al., “Neurological sequelae of 2009 influenza A (H1N1) in children: A case series observed during a pandemic,” Pediatr. Crit. Care Med., 11, No. 2, 179–184 (2010), doi: https://doi.org/10.1097/pcc.0b013e3181cf4652.
C. Hofmann, M. O. Baur, and H. Schroten, “Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence?” J. Neurol., (2010), doi:https://doi.org/10.1007/ s00415-010-5757-3.
J. Greenlee and M. Cortez, “Faculty of 1000 evaluation for N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes,” F1000 – Post-Pub lication Peer Review of the Biomedical Literature, doi: 10.3410/f.11778958.12871058.
L. Wong-Kisiel, T. Ji, D. Renaud, S. Kotagal, et al., “Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis,” Neurology, 74, No. 19, 1550–1551 (2010), doi: https://doi.org/10.1212/wnl.0b013e3181dd41a1.
H. Ishiura, S. Matsuda, M. Higashihara, et al., “Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab,” Neurology, 71, No. 23, 1921–1923 (2008), doi: https://doi.org/10.1212/01.wnl.0000336648.43562.59.
P. Acién, M. Acién, E. Ruiz-Maciá, and C. Martín-Estefanía, “Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases,” Orphanet J. Rare Dis., 9, No. 1, 78–82 (2014), doi: https://doi.org/10.1186/s13023-014-0157-x.
W. Splinter and N. Eipe, “Anti-NMDA receptor antibodies encephalitis,” Pediatric Anesthesia, 19, No. 9, 911–913 (2009), doi: https://doi.org/10.1111/j.1460-9592.2009.03085.x.
F. Graus, M. J. Titulaer, R. Balu, and J. Dalmau, “A clinical approach to diagnosis of autoimmune encephalitis,” Lancet Neurol., (2016), doi: https://doi.org/10.1016/S1474-4422(15)00401-9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 2, Iss. 1, pp. 110–116, February, 2017.
Rights and permissions
About this article
Cite this article
Vasenina, E.E., Levin, O.S., Gan’kina, O.A. et al. Autoimmune Anti-NMDA Receptor Encephalitis. Neurosci Behav Physi 48, 650–656 (2018). https://doi.org/10.1007/s11055-018-0612-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-018-0612-6